L.1,4 Mechanism of drug action/drug targets Flashcards

1
Q

What is affinity vs potency

A

Affinity: attraction of a ligand for a receptor - how easily they bind together
Potency: the ratio of response compared to the concentration (or dose) of agonist. - how little does it take to get a big response?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 6 potential drug targets

A

Ion channels, Enzymes, Carrier molecules and Receptors, Cytokines and DNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the 4 types of receptors, basic mechanism and their time scales of working

A
  1. Ligand gated ion channels: miliseconds
    specific ligands open channel that is selective for one ion through multiunit structure, by changing conformation of the “gate” allowing fast opening.
  2. G protein coupled receptors: seconds
    Ligand activates receptor which activates G protein which can go onto open ion channels or activate enzymes
  3. Tyrosine Kinase/cytokine linked receptors: hours/days: Ligand activates receptor/enzyme complex which starts phosphorylation leading to alteration of gene transcription
  4. Intracellular nuclear/Steroid receptors: Hours : Ligand is lipid soluble, crosses the membrane to find receptor in the cytosol. Activated receptor goes to nucleus to alter gene transcription.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Give examples of ionotropic receptor agonists good and bad

A
  • excitatory: ACh/glutamate agonists: increase Na+ and K+ permeability which increases depolarisation-> AP
  • inhibitory: GABAa agonists : increase opening frequency or duration of Cl- channels hyperpolarising cell
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how does a tyrosine kinase receptor work

A

Involved with mediating the actions of GF, cytokines and certain hormones, receptor funtions as an enzyme that transfers phosphate groups from ATP to tyrosine residues on intracellular target proteins . Eg, VEGFR2 protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

When do receptors undergo conformation change which leads to activation/ inhibition of cell signalling

A

Upon binding a neurotransmitter/hormone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How do drugs bind to receptors

A

4 different bonds in order of strength

Van der waals, hydrogen binding, ionic interactions, covalent (basically permanent).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How is Affinity measured

A

Fractional occupancy: measures fraction of receptors that have a ligand bound to a receptor when we add a particular concentration of ligand.
When there is a higher fraction of binding for a lower concentration of ligand (drug), the affinity is higher.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the relationship between affinity and actual biological response

A

The relationship between binding and response are not directly proportional. There is some amplification where low numbers of receptor occupancy can cause max response. Some factors downstream from receptor binding may interact to produce the final response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is EC50 (C for concentration - ED50 for dose)

On a graph of concentration of drug vs % effect

A

EC50 is the concentration of agonist where 50% of maximal response is produced. Used as measure of potency- where the lower the EC50, the more potent it is.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the difference between dose and concentration

A

Dose is the actual amount of medicine put in the body, whereas the concentration is the amount measured in the blood after pharmacokinetics has happened.
Later this concentration goes on to have an effect through pharmacodynamics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is efficacy and what is it measured by on a graph of concentration of drug vs % effect.

A

Efficacy: The ability of the drug to bind to receptor and cause a change in the receptors action.
Measured by Emax, conc when % effect is 100.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are agonists, inverse agonists, antagonists and their the affinity and efficacy characteristics.

A

Full Agonist: positive efficacy: raises activity level to max above basal rate. Increased affinity.
Partial agonist raises activity level below max above basal rate.

Inverse agonist: negative efficacy- decreases activity rate below basal

Antagonist: affinity but no efficacy- adds no addition to basal rate activity so can’t be stimulated to become higher.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the two types of Antagonist.

A

Reversible competitive: on/off binding to compete directly with agonist and therefore decrease response achievable by agonist: antagonist - but can be overcome with increased conc of agonist so max response can still be achieved. Most commonly used.

Irreversible competitive: covalent bonding reduces available sites for agonist reducing the max response achievable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is selectivity and the relevance to drug therapy

A

Selectivity is how drugs can preferentially bind to a certain subtype of receptor more than others.
It is important because although one compound can match with different subtype receptors from the same family, having a preferential binding for one subtype leads to a greater effect for that subtype. Subtypes affect different places and functions so you may not want to trigger the other subtypes for unwanted side effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Explain receptor plasticity using: receptor state and number. What is its clinical relevance

A

After short term exposure to an agonist the ability of receptors to produce an effect (receptor state) can change leading to desensitisation (disconnect it from signal transduction pathway)

-Receptor numbers/populations due to receptor synthesis rate change leading to up (chronic exposure to antagonist) or down regulation (chronic exposure to agonist)

This can lead to tolerance - reduced effectiveness of chronic drug use over time eg. salbutamol

17
Q

Compare desensitisation and internalisation

A

Desensitation: Agonist binding triggers a g protein receptor kinase to phosphorylate the intracellular side to stop g protein binding to receptor - stop signal transduction, rapid and reversible.

Internalisation is not long after this, a protein binding to the intracellular side of receptor causing it to be internalised and recycled to stop agonist binding altogether

18
Q

Describe the mechanism of a drug that targets carrier proteins- example, therapeutic use

A

Fluoxetine: blocks serotonin transporter protein that takes up serotonin from the synaptic cleft back to the presynaptic neuron, therefore increases levels of serotonin.

19
Q

Describe the mechanism of a drug that targets ion channels proteins- example

A

Ca+ channel blockers eg verapamil to decrease cardiac ionotropy.
Voltage gated sodium channels: local anaesthetic- block the pore and stop excitation, decrease signal conduction. Block pain signal.

20
Q

Describe an example of the mechanism of a drug that targets enzyme

A

Statins eg. Simvastatin target HMG CoA reductase to stop pathway of LDL cholesterol synthesis in hepatocytes.

21
Q

Describe the mechanism of a drug that targets receptors

A

Salbutamol targets B2 adrenergic receptor as an agonist for bronchodilation